Literature DB >> 20336478

Functional involvement of cone photoreceptors in advanced glaucoma: a multifocal electroretinogram study.

Ajoy Vincent1, Rohit Shetty, Sathi A V Devi, Mathew K Kurian, Ramgopal Balu, Bhujang Shetty.   

Abstract

The purpose of the study is (1) to demonstrate the anatomical variation of cone photoreceptor density across normal retina as a sectoral amplitude asymmetry of photopic multifocal electroretinogram (mfERG) and (2) to study the potential presence of sequential or differential, functional cone photoreceptor damage in glaucoma using this amplitude asymmetry. A 37-Block scaled mfERG was recorded from 22 controls and 27 glaucoma subjects. The N1 and P1 amplitudes of averaged responses from corresponding zones nasal and temporal to fovea were analyzed for asymmetry in controls and glaucoma subjects. Amplitude asymmetry was demonstrable for both N1 (p < 0.001) and P1 (p < 0.001) parameters in control subjects. Although this amplitude asymmetry was preserved in glaucoma subjects with moderate field defects, it was not demonstrable in patients with advanced field defects. The anatomical variation in cone photoreceptor distribution across normal retina is demonstrated as an amplitude asymmetry in first order kernel responses of mfERG. The cone photoreceptors in the region nasal to fovea appear to be affected only in advanced glaucoma possibly suggesting that photoreceptors could follow a sequential damage like the overlying neuroretinal rim in glaucoma.

Entities:  

Mesh:

Year:  2010        PMID: 20336478     DOI: 10.1007/s10633-010-9227-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  31 in total

1.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

2.  Count and density of human retinal photoreceptors.

Authors:  J B Jonas; U Schneider; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Clinical recognition of glaucomatous cupping.

Authors:  R E Kirsch; D R Anderson
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

4.  Electroretinography during short-term intraocular tension rise.

Authors:  B Karlberg; A Hedin; K Björnberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1968

5.  Electroretinographic changes in controlled chronic open-angle glaucoma.

Authors:  D L Alvis
Journal:  Am J Ophthalmol       Date:  1966-01       Impact factor: 5.258

6.  The b-wave of the dark adapted flash electroretinogram in patients with advanced asymmetrical glaucoma and normal subjects.

Authors:  I M Velten; F K Horn; M Korth; K Velten
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

7.  Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression.

Authors:  A Tuulonen; P J Airaksinen
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

8.  The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; R S Harwerth; E L Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

9.  Evidence for a ganglion cell contribution to the primate electroretinogram (ERG): effects of TTX on the multifocal ERG in macaque.

Authors:  D C Hood; L J Frishman; S Viswanathan; J G Robson; J Ahmed
Journal:  Vis Neurosci       Date:  1999 May-Jun       Impact factor: 3.241

10.  The mode of progressive disc cupping in ocular hypertension and glaucoma.

Authors:  J E Pederson; D R Anderson
Journal:  Arch Ophthalmol       Date:  1980-03
View more
  8 in total

1.  Assessment of macular function of glaucomatous eyes by multifocal electroretinograms.

Authors:  Nobuhide Hori; Shinya Komori; Hiroki Yamada; Akira Sawada; Yasunori Nomura; Kiyofumi Mochizuki; Tetsuya Yamamoto
Journal:  Doc Ophthalmol       Date:  2012-09-04       Impact factor: 2.379

2.  Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: an mfERG and OCT study.

Authors:  Saemi Park; In Hwan Cho; Tae Kwann Park; Woo Ho Nam; Young-Hoon Ohn
Journal:  Doc Ophthalmol       Date:  2012-12-20       Impact factor: 2.379

3.  The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure.

Authors:  Michael R R Böhm; Maurice Schallenberg; Katrin Brockhaus; Harutyun Melkonyan; Solon Thanos
Journal:  Lab Invest       Date:  2016-01-18       Impact factor: 5.662

4.  Ultra-high resolution profiles of macular intra-retinal layer thicknesses and associations with visual field defects in primary open angle glaucoma.

Authors:  Qi Chen; Shenghai Huang; Qingkai Ma; Huiling Lin; Mengmeng Pan; Xinting Liu; Fan Lu; Meixiao Shen
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

5.  Optimizing a Portable ERG Device for Glaucoma Clinic: The Effect of Interstimulus Frequency on the Photopic Negative Response.

Authors:  Flora Hui; Jessica Tang; Xavier Hadoux; Michael Coote; Jonathan G Crowston
Journal:  Transl Vis Sci Technol       Date:  2018-12-21       Impact factor: 3.283

6.  Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model.

Authors:  Maximilian Weiss; Sabrina Reinehr; Ana M Mueller-Buehl; Johanna D Doerner; Rudolf Fuchshofer; Gesa Stute; H Burkhard Dick; Stephanie C Joachim
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

7.  Relationship Between Deep Retinal Macular Vessel Density and Bipolar Cell Function in Glaucomatous Eyes.

Authors:  Yuji Yoshikawa; Takuhei Shoji; Junji Kanno; Hirokazu Ishii; Minami Chino; Yuro Igawa; Kei Shinoda; Yozo Miyake
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

8.  Analyzing the impact of glaucoma on the macular architecture using spectral-domain optical coherence tomography.

Authors:  Jan D Unterlauft; Matus Rehak; Michael R R Böhm; Franziska G Rauscher
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.